Science World ReportBoehringer Pays $650 Million to End Blood-Thinner CasesBloombergBoehringer Ingelheim GmbH, the German family-owned drugmaker, agreed to pay $650 million to settle the majority of lawsuits filed over its blood thinner Pradaxa, which has been linked to more than 500 patient deaths. Boehringer, slated to face the first U.S. …Boehringer Ingelheim Settles Dabigatran (Pradaxa) Lawsuits for $650 MillionMedscapeBoehringer to settle lawsuits against blockbuster drug for $650 millionReutersGerman Drug Manufacturer Agrees to $650 Million Settlement for Blood Thinner …Science World ReportCardiovascular Business -Forbes -Suburban Journalsall 17 news articles …Read Full Story
Boehringer Pays $650 Million to End Blood-Thinner Cases - Bloomberg
Real Estate of Cebu
